BioStock video interview with Follicum’s CEO Jan Alenfall

September 13, 2019

BioStock video interview with Follicum’s CEO Jan Alenfall

This week the yearly event Nordic Life Science Days (NLSDays) took place in Malmö, Sweden. BioStock took the opportunity to talk to Jan Alenfall, the CEO of Follicum, about the status of the company’s projects – hair growth and diabetes.

See the interveiw, in English, here.

For further information, please contact:
Jan Alenfall – CEO, Follicum AB
Telephone: +46 46 19 21 97

About Follicum AB
Follicum is a biotech company focusing on the discovery and development of peptide-based drugs. The primary focus is in hair growth stimulation, where Follicum has obtained very promising results with FOL-005 in a recently completed clinical trial. In diabetes, Follicums research has resulted in a new peptide class which significantly increases the release of insulin in pre-clinical models. The company was founded in 2011, and is based in Lund, Sweden. Follicum is listed on the Swedish small cap exchange Spotlight since 2014.